To cite this article: Scheres LJJ, Brekelmans MPA, Beenen LFM, B€ uller HR, Cannegieter SC, Middeldorp S. Sex-specific differences in the presenting location of a first venous thromboembolism. J Thromb Haemost 2017; 15: 1344-50.
Essentials
• Whether the location of venous thromboembolism (VTE) differs between the sexes is not known.
• Pulmonary embolism as presenting location was relatively more common in women than in men.
• The difference was consistent among age groups and most prominent in unprovoked VTE.
• The underlying mechanism remains to be elucidated.
Summary. Background:
The risk of venous thromboembolism (VTE) differs between men and women. Some risk factors seem to influence the presenting location of VTE. Sex-specific differences in the presenting VTE location have not been studied extensively. Methods: We analyzed data from the MEGA case-control study and the Hokusai-VTE study, and used published data from the RIETE registry. Data from patients with a symptomatic first VTE were included (MEGA, n = 4953; Hokusai-VTE, n = 6720; RIETE, n = 40 028). Distributions of deep vein thrombosis (DVT), pulmonary embolism (PE) and combined DVT and PE as the presenting VTE location were calculated for men and women, and presented as proportions with 95% confidence intervals (CIs). Sex-specific differences were explored for different age categories and for unprovoked and provoked events. Results: In the MEGA study, PE was the presenting location in 35.5% of women and in 29.5% of men with VTE (difference 6.0%, 95% CI 3. 4-8.6 ). In the Hokusai-VTE study, these proportions were 35.1% for women and 25.2% for men (difference 10.0%, 95% CI 7.8-12.2). In the RIETE registry, PE (with or without DVT) was also observed more often as the presenting location in women (53.3%) than in men (47.7%), with a difference of 5.6% (95% CI 4.7-6.6). The observed higher proportion of PE as the presenting location in women was present in all age groups and was most prominent among unprovoked VTE events. Conclusions: In three large studies, the distribution of the presenting VTE location differed consistently between the sexes, whereby PE was more often the primary location of presentation in women than in men.
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Background
The incidence, risk factors, clinical presentation and course of a disease often differ between men and women [1] . Identification of these differences and their causes is of importance to optimize the diagnosis and management of a disease by means of sex-specific strategies [2] . Sexspecific differences also exist for venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE). Women are at higher risk during their fertile life, mainly because of the effects of endogenous and exogenous hormones [3] . In contrast, men are at higher risk at older ages [4] . In addition, several risk factors seem to influence the presenting location of VTE. Some are observed more often in DVT than in PE, whereas other risk factors are associated with a higher PE incidence. For example, oral contraceptive use and carriership of factor V Leiden (which is known as the FV Leiden paradox) affect the risk of DVT much more than that of PE [5] [6] [7] , whereas pulmonary diseases seem to be stronger risk factors for PE than for DVT [8] [9] [10] . Also, when patients with an initial DVT have a recurrent event it is more likely to be another DVT than a PE, whereas patients with a recurrence after an initial PE more often have another PE instead of DVT [11] [12] [13] . The presenting location of a VTE is relevant, as the impact of a PE is often higher than that of a DVT [14] . The underlying mechanism that influences the presenting VTE location is poorly understood. Moreover, sex-specific differences in the presenting VTE location have not been studied extensively. Therefore, we set out to explore sex-specific differences in the presenting VTE location.
Methods
For the evaluation of differences in the distributions of DVT, PE and combined DVT and PE as the presenting location among men and women with a first episode of VTE, data from the Multiple Environmental and Genetic Assessment (MEGA) study were first analyzed [15] . The Hokusai-VTE study was used for validation [16] . Finally, confirmation was obtained by using published data from the Registro Informatizado de Enfermedad TromboEmb olica (RIETE) registry [17] .
MEGA case-control study
The MEGA study is a large case-control study, and the details of the design have been described previously [15] . Briefly, consecutive patients aged 18-70 years with a first VTE were included from one of six (Amersfoort, Amsterdam, The Hague, Leiden, Rotterdam, and Utrecht) anticoagulation clinics in the Netherlands between March 1999 and September 2004. Eighty-six per cent of eligible patients participated in the MEGA study. Participants completed a detailed questionnaire on VTE risk factors, and were asked to provide a blood sample and DNA. Detailed information on diagnoses was acquired from hospital discharge reports and data from general practitioners. All participants provided written informed consent. The study was approved by the Medical Ethical Committee of the Leiden University Medical Center, Leiden, the Netherlands. For the current analyses, patients with a chromosomal disorder (n = 1) of the sex chromosomes (e.g. Klinefelter syndrome) or persons undergoing a sex change (n = 2) were excluded.
Hokusai-VTE study
The Hokusai-VTE study (ClinicalTrials.gov identifier: NCT00986154) was a large, international randomized double-blind study recruiting from January 2010 through October 2012 that compared heparin/edoxaban with heparin/warfarin in patients with acute symptomatic DVT or PE [16] . Patients aged ≥ 18 years could participate if they had objectively diagnosed acute symptomatic DVT of the popliteal, femoral or iliac veins, or an acute symptomatic PE (with or without DVT). In the Hokusai-VTE study, there was a minimum PE/DVT event ratio of 2 : 3. Edoxaban (or placebo) was started at a dose of 60 mg once daily (or the dose was adjusted according to specific criteria); warfarin (or placebo) was dosed according to the International Normalized Ratio. The primary efficacy outcome of the Hokusai-VTE study was a composite of recurrent DVT, non-fatal PE, or fatal PE. Pregnant patients could not participate in the study. All patients provided written informed consent. The institutional review board at each participating center approved the protocol. The Hokusai-VTE study was funded by Daiichi-Sankyo.
RIETE registry
We used data from the RIETE registry, which were published previously by Blanco-Molina et al. [17] . This is a large ongoing registry (initiated in 2001) of acute symptomatic VTE patients that is used in > 10 countries.
Presenting location of VTE
In all three studies, a VTE diagnosis was guided by the presenting symptomology; for example, if chest symptoms constituted the major cause of a patient coming to medical attention, chest imaging was ordered. In cases of a PE diagnosis, in the absence of DVT symptoms, ultrasound of the legs is typically not routinely performed in clinical practice. A diagnosis was confirmed by objective imaging tests such as ultrasonography or venography for DVT, and computed tomography, lung scintigraphy or pulmonary angiography for PE. In the MEGA and Hokusai-VTE studies, the presenting locations could be classified into DVT, PE, and combined DVT and PE. From the published data of the RIETE registry, only a subdivision into DVT or PE with or without DVT could be made.
Statistical analysis
Proportions and differences in proportions of DVT, PE and combined DVT and PE of first VTE events were calculated with their 95% confidence intervals (CIs) for men and women. Next, these differences were explored in different age categories, i.e. < 30, 30-45, 46-60 and > 60 years. Subsequently, we investigated differences in the presenting VTE location among unprovoked and provoked events. In the MEGA study, provoked events were defined as a VTE triggered by one or more of the following: recent surgery, trauma or immobilization, pregnancy or puerperium, long-distance travel, active malignancy in the past 5 years, or the use of estrogen-containing drugs. In the Hokusai-VTE dataset, the definition for provoked events was a VTE triggered by one or more of the following: recent surgery, trauma or immobilization, puerperium, active cancer, sitting for > 4 h, active cancer, a known thrombophilic condition, or the use of estrogen-containing drugs. Finally, as the use of oral contraceptives in women and carriership of the FV Leiden variant are known to influence VTE location (e.g. predominance of DVT over PE) [5] [6] [7] , these risk factors were explored in detail in the available data of the MEGA study.
Results
Data on the presenting VTE location of participants of the MEGA study (n = 4953), the Hokusai-VTE study (n = 6720) and the RIETE registry (n = 40 028) with a first episode of VTE were included in the current analysis. General characteristics of the MEGA and Hoskusai-VTE study populations were available, and are shown in Table 1 . Table 2 shows the distribution of DVT, PE and combined DVT and PE as the presenting location for each of the three studies. In the MEGA study, PE was the presenting location in 35.5% of women and in 29.5% of men (difference 6.0%, 95% CI 3.4-8.6). In the Hokusai-VTE study, PE was the presenting location in 35.1% of women and in 25.2% of men (difference 10.0%, 95% CI 7.8-12.2). In the RIETE registry, PE (with or without DVT) as the presenting location was also more frequently observed in women (53.3%) than in men (47.7%), with a difference in proportion of 5.6% (95% CI 4.7-6.6). With respect to this classification in the RIETE registry, in the MEGA and Hokusai-VTE studies, PE with or without DVT was also more frequently the presenting location in women than in men, with the differences between women and men being 3.2% (95% CI 0.3-5.9) and 8.5% (95% CI 6.2-10.9), respectively. Table 3 shows the sex-specific distribution of DVT, PE and combined DVT and PE as the presenting location for a total of 11 671 patients with a first VTE in different age categories from the MEGA and Hokusai-VTE studies ( Fig. S1 shows a summary of these findings). The observed higher proportion of PE as a presenting location in women than in men was observed in all age groups. The largest differences in the proportion of PE as the presenting location were detected in the age categories 30-45 years (difference between women and men: MEGA, 5.6%, 95% CI 0.6-10.5; and Hokusai-VTE, 8.0%, 95% CI 3.5-12.6) and > 60 years (difference between women and men: MEGA, 12.9%, 95% CI 7.0-18.7; and Hokusai-VTE, 11.3%, 95% CI 7.8-14.8). Only in the youngest age group (< 30 years) was there no clear difference in the proportion of presenting location between men and women in the MEGA study (difference À 1.1%, 95% CI À 11.7 to 8.7). However, in the Hokusai-VTE study, PE as the presenting location was again found more often in women than in men in this age group, i.e. 16.0% (95% CI 7.9À23.7). This discrepancy might be explained by the inclusion of pregnant women in the MEGA study, and the exclusion of pregnant women in the Hokusai-VTE study [18] .
The proportion of unprovoked VTE events was smaller in women than in men (Table 4) , particularly in the Hokusai-VTE study (1545 of 2928 [52%] of all women had an unprovoked VTE, as compared with 2702 of 3792 [71%] of all men). For unprovoked VTE events, the difference between men and women in PE as the presenting location was most pronounced (difference between women and men: MEGA study, 15.0%, 95% CI 9.6-20.3; Hokusai-VTE study, 10.9%, 95% CI 8.1-13.8).
In the MEGA study, in 67 of 329 (20.4%) of female patients with a heterozygous FV Leiden variant, PE was the presenting location; this was the case in 50 of 317 (15.8%) of the men who carried this variant (difference 4.6%, 95% CI À 1.4 to 10.5). In the group without a heterozygous FV Leiden mutation, 747 of 1983 (37.7%) of the women and 527 of 1626 (32.4%) of the men had PE as the presenting location (absolute difference 5.3%, 95% CI 2.1-8.4).
Of all women aged ≤ 50 years in the MEGA study who used oral contraceptives, 342 of 1103 (31.0%) had PE as the presenting location; there were 214 of 531 (40.3%) women aged ≤ 50 years who did not use oral contraceptives (absolute difference 9.3%, 95% CI 4.3-14.3).
Discussion
In this analysis, which used data from three large independent studies, we observed consistent differences in the proportions of predominant presenting VTE location between men and women, whereby the presenting location was more often PE in women and more often DVT in men. This finding was most prominent among unprovoked VTE cases, and was consistent among age groups. For the interpretation of these results, we should emphasize that our results are conditional probabilities; that is, given that a person has developed VTE, the likelihood of presenting with PE is higher in women than in men. To be able to fully understand our findings, absolute risks, i.e. incidence rates, are needed. From most incidence studies that are available, it appears that these rates often do not differ considerably between men and women [19] [20] [21] [22] [23] [24] [25] [26] . This finding is, however, in contrast to the incidence rates for recurrence, which are consistently found to be approximately two-fold higher in men than in women [27] [28] [29] [30] [31] . This paradox can be explained by the fact that women are exposed to more risk factors than men, i.e. in addition to all regular risk factors, to hormone use and pregnancy. These common exposures 'artificially' raise the risk of a first VTE in women. Indeed, in a recent study in which this was taken into account, we found that the risk of a first event in men was also approximately two-fold higher than in women, thus explaining the paradox [4] . We can therefore assume that men have a higher intrinsic VTE risk, and women a higher extrinsic VTE risk (owing to more exposure to risk factors). Moreover, female-specific risk factors such as the use of oral contraceptives and pregnancy lead to a larger DVT than PE risk [5] . This is reflected in our results, which show that the proportion of PE becomes even higher in women when these factors are disregarded, i.e. in the unprovoked cases.
With the findings from our study, we can merely speculate on potential underlying mechanisms for the observed differences in the presenting location. A first mechanism, which has been proposed before, and that could explain a higher proportion of DVT as the presenting location in men, is that men are, on average, taller and have longer legs than women. This may lead to more susceptibility to stasis in the lower extremities in men [24] . Increased stasis in the lower extremities could thereby increase DVT risk. A second explanation for the observed differences is the possibility that clots in women are more fragile or unstable than in men, potentially leading to increased embolization rates. A third option could be that there is variability between men and women in the anatomic origin of thromboses, as is exemplified by cerebral venous sinus thrombosis, which predominantly occurs in women [32] . Women might be more prone to the development of a local thrombus in the pulmonary arteries or right side of the heart. The potential association between atrial fibrillation and pulmonary embolism has not been fully elucidated, and might play a role [33] . Although the incidence of atrial fibrillation is higher in men, the incidence of thrombotic events is higher in women with atrial fibrillation [34] . Thrombi could also be formed at yet another sex-specific anatomic site, such as the ovarian or uterine veins, and embolize to the lungs, and hence not CI, confidence interval. *Numbers estimated from available data from [17] .
lead to symptoms of DVT. Ovarian vein thrombosis is rare, although symptoms are often ambiguous and diagnosis is difficult with imaging without contrast [35, 36] .
Furthermore, another possible explanation could be that, in women, an asymptomatic May-Turner syndrome with silent proximal DVT is more prevalent than in men. Table 3 Sex-specific proportions of deep vein thrombosis (DVT), pulmonary embolism (PE) and combined DVT and PE as a presenting location in different age categories for patients with a first venous thromboembolism (VTE) in the MEGA and Hokusai-VTE studies
Difference between women and men, % (95% CI)
Difference between women and men, % (95% CI) CI, confidence interval. *MEGA study. VTE triggered by one or more of the following: active malignancy in the past 5 years; recent surgery, trauma, immobilization, pregnancy, puerperium, long-distance travel, or use of estrogen-containing drugs. †Hokusai-VTE. VTE triggered by one or more of the following: active cancer; recent surgery, trauma, immobilization, use of estrogen-containing drugs, puerperium, sitting for > 4 h, or known thrombophilic condition.
A last possibility could be that men and women experience signs and symptoms in a different way, as is the case for many (cardiovascular) diseases. Men might be more aware of symptoms of the leg or calf, whereas women might notice chest symptoms earlier. Another possibility is that men with chest pain are typically suspected of having myocardial infarction, whereas women with chest pain might be suspected of having PE earlier on. A major strength of this study is the use of combined data from three large studies including > 50 000 subjects. Moreover, all three studies had different designs, increasing the generalizability of the observed results. Although the included populations in the studies differ slightly, the distributions of the presenting location of a first VTE in the studies are consistent.
A limitation of this study, as mentioned above, is that only relative occurrence could be determined. Therefore, further research is necessary to complement the current results. Incidence data are needed to allow stratification for the sexes, by age and by exposure to female-specific risk factors, for the outcomes PE, DVT and PE with DVT separately.
Another limitation is that, in the data from the RIETE registry, only distributions of DVT or PE with or without DVT as the presenting location were available. Despite this, the larger proportion of PE with or without DVT in women than in men definitely points towards a higher PE proportion in women, and is therefore consistent with the MEGA and Hokusai-VTE observations. A third limitation, selection bias, could have explained the findings if, for example, men with PE or women with DVT had been less likely to participate in any of the three studies. However, it is very unlikely that this has occurred at such a large scale in all three studies. Finally, it is possible that diagnostic strategies differed slightly among participating sites in the three studies; however, this would be unlikely to change the results. For example, if, hypothetically, a selection of patients with a PE diagnosis had also undergone routine ultrasound examination of the lower extremities, in the absence of DVT symptoms, this would only have influenced the results in the unlikely scenario that this would have been systematically performed in men only but not in women or vice versa.
To our knowledge, this is the first study to extensively analyze differences in the presenting VTE location between men and women. The findings show that the distribution of the presenting location of a first VTE differed consistently between the sexes, whereby PE was more often the primary location of presentation in women than in men. This finding was independent of age and was more pronounced for unprovoked VTE events. The underlying mechanism is unknown, and requires further investigation. The results of this study may have some clinical relevance, as VTE that presents as PE is associated with decreased survival rates as compared with VTE that presents as DVT [14] . This study emphasizes the sexspecific differences in VTE.
